We are live on
!
Find out more
TI
Turner Investments Portfolio holdings
AUM
$134K
1-Year Est. Return
49.03%
This Fund
S&P 500
This Quarter
Est. Return
-6.03%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
–
AUM
$494M
AUM Growth
-$52.3M
(-9.6%)
Cap. Flow
+$2.34M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
338
New
96
Increased
67
Reduced
60
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.18M |
| 2 |
Eli Lilly
LLY
|
+$6.91M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$6.05M |
| 4 |
Constellation Brands
STZ
|
+$5.2M |
| 5 |
Newell Brands
NWL
|
+$4.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Affiliated Managers Group
AMG
|
+$5.97M |
| 2 |
SUNE
SUNEDISON, INC COM
SUNE
|
+$5.31M |
| 3 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$5.28M |
| 4 |
Apple
AAPL
|
+$5.22M |
| 5 |
Cencora
COR
|
+$4.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.41% |
| 2 | Technology | 21.72% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 8.06% |
| 5 | Consumer Staples | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PXD
126
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.21M | 0.24% |
+9,920
| New | +$1.24M |
|
127
Century Communities
CCS
$1.96B
| $1.19M | 0.24% |
+60,000
| New | +$1.25M |
|
128
Papa John's
PZZA
$811M
| $1.16M | 0.24% |
17,000
-10,670
| -39% | -$769K |
|
|
MPG
129
DELISTED
Metaldyne Performance Group Inc.
MPG
| $1.16M | 0.23% |
+55,000
| New | +$1.08M |
|
|
VASC
130
DELISTED
Vascular Solutions Inc
VASC
| $1.13M | 0.23% |
35,000
+5,610
| +19% | +$201K |
|
131
McKesson
MCK
$102B
| $1.13M | 0.23% |
6,115
+3,015
| +97% | +$639K |
|
|
CPRX
132
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.1M | 0.22% |
366,490
+80,120
| +28% | +$346K |
|
133
Ironwood Pharmaceuticals
IRWD
$701M
| $1.09M | 0.22% |
+125,191
| New | +$1.17M |
|
134
Boston Scientific
BSX
$71.4B
| $1.09M | 0.22% |
+66,400
| New | +$1.13M |
|
|
STDY
135
DELISTED
SteadyMed Ltd
STDY
| $1.07M | 0.22% |
302,267
-104,790
| -26% | -$478K |
|
|
ICPT
136
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.07M | 0.22% |
6,460
-11,110
| -63% | -$2.44M |
|
137
Alphabet (Google) Class A
GOOGL
$4.38T
| $1.07M | 0.22% |
+33,400
| New | +$1.08M |
|
138
Cardiff Oncology
CRDF
$74.7M
| $1.06M | 0.21% |
2,578
-21
| -0.8% | -$11K |
|
139
AMN Healthcare
AMN
$1.19B
| $1.05M | 0.21% |
+35,000
| New | +$1.16M |
|
140
Amphastar Pharmaceuticals
AMPH
$873M
| $1.05M | 0.21% |
89,750
-65,530
| -42% | -$983K |
|
141
Aptiv
APTV
$9.61B
| $1.05M | 0.21% |
13,780
-2,020
| -13% | -$155K |
|
142
Essent Group
ESNT
$6.04B
| $1.03M | 0.21% |
41,500
-71,910
| -63% | -$1.98M |
|
|
PTX
143
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $1.03M | 0.21% |
+32,599
| New | +$1.56M |
|
144
PepsiCo
PEP
$189B
| $1.03M | 0.21% |
10,900
+4,120
| +61% | +$392K |
|
145
EOG Resources
EOG
$71.4B
| $1.02M | 0.21% |
14,020
+1,680
| +14% | +$131K |
|
|
AKTX
146
Akari Therapeutics
AKTX
$14.1M
| $1M | 0.2% |
+52
| New | +$615K |
|
|
PRTK
147
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1M | 0.2% |
+52,720
| New | +$1.31M |
|
|
ITCI
148
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $977K | 0.2% |
+24,400
| New | +$796K |
|
|
LXFT
149
DELISTED
Luxoft Holding, Inc.
LXFT
| $949K | 0.19% |
+15,000
| New | +$934K |
|
|
CORI
150
DELISTED
Corium International, Inc.
CORI
| $935K | 0.19% |
+100,000
| New | +$1.2M |
|
Similar funds
IP
DVC
PAM
CCM
GA
IPLA
LRM
HC
Turner Investments's Q3 2015 Portfolio in Review
As of Q3 2015, Turner Investments held 338 positions worth $494M, down 9.6% from $547M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Turner Investments's Q3 2015 filing shows 96 new, 67 increased, 60 reduced and 100 closed positions. Its largest new stake was Eli Lilly: 81,890 shares worth $6.85M. The largest sale was Affiliated Managers Group, an estimated $5.97M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
- Turner Investments's largest Q3 2015 buy was Eli Lilly: 81,890 shares worth $6.85M.
- Turner Investments added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015, an estimated $7.18M increase.
- Turner Investments's biggest Q3 2015 reduction was Apple, cutting an estimated $5.22M.
- Turner Investments fully exited Affiliated Managers Group in Q3 2015, selling an estimated $5.97M.
- Turner Investments's ten largest holdings make up 16% of its $494M portfolio in Q3 2015.
- Turner Investments opened 96 new positions and closed 100 in Q3 2015.
- Turner Investments's portfolio value fell 9.6% quarter-over-quarter to $494M.
Based on Turner Investments's 13F filing for Q3 2015, filed 12 Nov 2015.